We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+0.35%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
10 Year Est. Return
AUM
$335M
AUM Growth
+$5.97M
Cap. Flow
+$10.1M
Cap. Flow %
3%
Top 10 Hldgs %
27.92%
Holding
666
New
47
Increased
170
Reduced
94
Closed
28

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.02M
2
WRB icon
W.R. Berkley
WRB
+$1.01M
3
AMZN icon
Amazon
AMZN
+$842K
4
GD icon
General Dynamics
GD
+$368K
5
NTR icon
Nutrien
NTR
+$344K

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$501K
2
CVS icon
CVS Health
CVS
+$368K
3
BMY icon
Bristol-Myers Squibb
BMY
+$359K
4
PLTR icon
Palantir
PLTR
+$244K
5
FISV
Fiserv Inc
FISV
+$204K

Sector Composition

Rank Sector Weight
1 Technology 17.74%
2 Healthcare 14.93%
3 Financials 13.98%
4 Industrials 10.27%
5 Communication Services 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNL icon
526
Travel + Leisure Co
TNL
$4.78B
$6.31K ﹤0.01%
125
ABNB icon
527
Airbnb
ABNB
$90.5B
$5.91K ﹤0.01%
45
VSS icon
528
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.7B
$5.72K ﹤0.01%
+50
New +$6.01K
MCK icon
529
McKesson
MCK
$99.6B
$5.7K ﹤0.01%
+10
New +$5.6K
FLG
530
Flagstar Bank National Association
FLG
$6B
$5.63K ﹤0.01%
604
SMH icon
531
VanEck Semiconductor ETF
SMH
$72.3B
$5.57K ﹤0.01%
23
IEF icon
532
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
$5.46K ﹤0.01%
59
+50
+556% +$4.72K
ZS icon
533
Zscaler
ZS
$26.3B
$5.41K ﹤0.01%
30
HUN icon
534
Huntsman Corp
HUN
$1.8B
$5.41K ﹤0.01%
300
-500
-63% -$10.4K
FHLC icon
535
Fidelity MSCI Health Care Index ETF
FHLC
$3.32B
$5.36K ﹤0.01%
82
AMP icon
536
Ameriprise Financial
AMP
$49.4B
$5.32K ﹤0.01%
10
MU icon
537
Micron Technology
MU
$1.04T
$5.05K ﹤0.01%
60
SPHR icon
538
Sphere Entertainment
SPHR
$5.87B
$5.04K ﹤0.01%
+125
New +$5.23K
FXR icon
539
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$769M
$4.86K ﹤0.01%
65
VOE icon
540
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$4.85K ﹤0.01%
30
+10
+50% +$1.69K
AIG icon
541
American International
AIG
$42.3B
$4.82K ﹤0.01%
66
MCHP icon
542
Microchip Technology
MCHP
$42.6B
$4.76K ﹤0.01%
83
IUSV icon
543
iShares Core S&P US Value ETF
IUSV
$27.6B
$4.63K ﹤0.01%
50
+20
+67% +$1.92K
NVRI icon
544
Enviri
NVRI
$653M
$4.62K ﹤0.01%
+600
New +$5.01K
AB icon
545
AllianceBernstein
AB
$3.47B
$4.6K ﹤0.01%
124
KOP icon
546
Koppers
KOP
$988M
$4.54K ﹤0.01%
+140
New +$5K
SNAP icon
547
Snap
SNAP
$8.8B
$4.31K ﹤0.01%
400
-100
-20% -$1.13K
SPRY icon
548
ARS Pharmaceuticals
SPRY
$528M
$4.22K ﹤0.01%
400
BIDU icon
549
Baidu
BIDU
$37.8B
$4.22K ﹤0.01%
50
IXN icon
550
iShares Global Tech ETF
IXN
$8.85B
$4.15K ﹤0.01%
49

Similar funds

Brown, Lisle/Cummings's Q4 2024 Portfolio in Review

As of Q4 2024, Brown, Lisle/Cummings held 666 positions worth $335M, up 1.8% from $329M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $10.1M of net new capital in Q4 2024, opening 47 new positions and adding to 170 existing holdings. Its largest new stake was W.R. Berkley: 16,780 shares worth $982K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was T. Rowe Price, an estimated $501K trimmed.

  • Brown, Lisle/Cummings's largest Q4 2024 buy was W.R. Berkley: 16,780 shares worth $982K.
  • Brown, Lisle/Cummings added most to Eli Lilly in Q4 2024, an estimated $1.02M increase.
  • Brown, Lisle/Cummings's biggest Q4 2024 reduction was T. Rowe Price, cutting an estimated $501K.
  • Brown, Lisle/Cummings fully exited TransUnion in Q4 2024, selling an estimated $20.9K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $335M portfolio in Q4 2024.
  • Brown, Lisle/Cummings opened 47 new positions and closed 28 in Q4 2024.
  • Brown, Lisle/Cummings's portfolio value rose 1.8% quarter-over-quarter to $335M.

Based on Brown, Lisle/Cummings's 13F filing for Q4 2024, filed 27 Jan 2025.